≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of other and ill-defined sites

DOID EFO MESH SNOMED PheWeb

C3_OTHER_OR_ILLDEFINED_SITES

benign neoplasm: A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Cause of death: ICD-10 C76
Cause of death: ICD-9 195
Cause of death: ICD-8 195
Cancer registry: Topography ICD-O-3 C76

113

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions C.O.D: 10, 8, 9

113

diagram downward connector

Check minimum number of events None

113

diagram downward connector

Include endpoints None

113

diagram downward connector
C3_OTHER_OR_ILLDEFINED_SITES

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF4

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 113 39 74
Unadjusted prevalence (%) 0.03 0.02 0.05
Mean age at first event (years) 66.46 68.10 65.61

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_OTHER_OR_ILLDEFINED_SITES – Malignant neoplasm of other and ill-defined sites
GWS hits:

Survival analyses between endpoints

↥

Plot

before Malignant neoplasm of other and ill-defined sites
after Malignant neoplasm of other and ill-defined sites

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Malignant neoplasm of other and ill-defined sites

↥